Log in to search using one of your social media accounts:

 

ImmunoPET: the future of lung scans in aspergillosis?
Wed, 11/15/2017 - 11:48News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 15, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Vitamin D deficiency and aspergillosis
Mon, 11/06/2017 - 17:31News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 6, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Hologic to retain CEO MacMillan | Personnel Moves – November 3, 2017
Hologic (NSDQ:HOLX) said this week its current prez and CEO Stephen MacMillan will stay on with the company, resolving rumors that he may depart it to take up the corner office at Zimmer Biomet (NYSE:ZBH). In an SEC filing, the Marlborough, Mass.-based company’s board said it approved a special “performance-based retention equity grant” to MacMillan after he had begun to receive interest from other medical device firms. “Mr. MacMillan has led a dramatic turnaround of Hologic since joining in December 2013. The company’s performance has increased significantly under his...
Source: Mass Device - November 3, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News ConMed Corp. Hologic Invacare kentimaging Meritech Capital Partners Pulmatrix Inc. Sanofi-Aventis Smith & Nephew Tissue Regenix zimmerbiomet Source Type: news

Did Ötzi the Iceman have aspergillosis?
Did Ötzi the Iceman have aspergillosis?Wed, 10/25/2017 - 12:46News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 25, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Chronic Pulmonary Aspergillosis IV
Monday, October 16, 2017 - 08:36Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 16, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Chronic Pulmonary Aspergillosis III
Monday, October 16, 2017 - 08:35Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 16, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Chronic Pulmonary Aspergillosis II
Monday, October 16, 2017 - 08:34Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 16, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Chronic Pulmonary Aspergillosis I
Monday, October 16, 2017 - 08:32Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 16, 2017 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis
Ambruticins are a family of polyketides. The antifungal activity of an ambruticin,KOSN-2079, was tested in the mouse model of invasive aspergillosis.KOSN-2079 significantly reduced pulmonary fungal burdens and improved survival over that with the vehicle control. These results support the continued development of ambruticins as antifungal agents. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Efficacy of the investigational echinocandin ASP9726 in a guinea pig model of invasive pulmonary aspergillosis
ASP9726 is an investigational echinocandin with in vitro activity against Aspergillus species. We evaluated the pharmacokinetics and efficacy of this agent in an established guinea pig model of invasive pulmonary aspergillosis.ASP9726 plasma concentrations were measured in guinea pigs administered either a single dose or multiple doses of this agent at 2.5, 5, and 10 mg/kg of body weight/day by subcutaneous injection. Immunosuppressed guinea pigs were inoculated with A. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 10, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Researchers help develop new antifungal drug
(University of Liverpool) University researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 6, 2017 Category: International Medicine & Public Health Source Type: news

8th Advances Against Aspergillosis: scholarship application deadline
Date: Wednesday, September 20, 2017Year: 2018Location: Lisbon, PortugalContent-type: current_conferences (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - September 20, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

8th Advances Against Aspergillosis: abstract submissions deadline
Date: Wednesday, September 20, 2017Year: 2018Location: Lisbon, Portugal.Content-type: current_conferences (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - September 20, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Management of allergic and chronic pulmonary aspergillosis: part 3
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - September 19, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Disease Maps: Aspergillosis Stakeholders
News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - September 13, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Map of People with Aspergillosis
Add yourself to our worldwide map - no real names needed!World map of Aspergillosis (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - September 11, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death
Humans inhale mold conidia daily and typically experience lifelong asymptomatic clearance. Conidial germination into tissue-invasive hyphae can occur in individuals with defects in myeloid function, although the mechanism of myeloid cell–mediated immune surveillance remains unclear. By monitoring fungal physiology in vivo, we demonstrate that lung neutrophils trigger programmed cell death with apoptosis-like features in Aspergillus fumigatus conidia, the most prevalent human mold pathogen. An antiapoptotic protein, AfBIR1, opposes this process by inhibiting fungal caspase activation and DNA fragmentation in the murin...
Source: ScienceNOW - September 7, 2017 Category: Science Authors: Shlezinger, N., Irmer, H., Dhingra, S., Beattie, S. R., Cramer, R. A., Braus, G. H., Sharon, A., Hohl, T. M. Tags: Immunology reports Source Type: news

Global Aspergillosis Statistics
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - July 20, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Communication and Digital Content Officer, National Aspergillosis Centre
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - June 15, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Pharmacodynamics of F901318 against Aspergillus fumigatus in a rabbit model of invasive pulmonary aspergillosis (IPA)
Talk given at ECCMID 2017 by William Hope (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Transcriptomic regulatory analysis of the dendritic cell response to post-lung transplant invasive aspergillosis
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Targeted imaging of invasive aspergillosis
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Innate and adaptive immune defects in chronic pulmonary aspergillosis
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Management and outcome of culture-positive invasive aspergillosis in an area with high prevalence of voriconazole resistance
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Aspergillosis - the role of the fungus
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Aspergillosis - the role of the host
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Non-neutropenic patients and aspergillosis
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Retrospective observational cohort study comparing the management and outcome of culture-positive invasive aspergillosis due to Aspergillus fumigatus with wildtype and non-wildtype triazole susceptibility
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 26, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Aspergillus infection in patients supported on extracorporeal membrane oxygenation (ECMO).
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 26, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Multi-modal imaging and non-invasive detection of Aspergillus infection in a rat model
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 26, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Optimal cut-offs for Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA) in Europe
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 26, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Analysis of genes regulating the production of the invasive aspergillosis biomarker bis (methylthio) gliotoxin within genus Aspergillus and other opportunistic fungi
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 26, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Metabolic fingerprinting as a diagnostic tool for invasive aspergillosis: a pilot study
Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 26, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Aspergillosis Meeting Report, Sari, Iran
A meeting on aspergillosis was held in Sari, Iran, 8-10 November 2016. For a short report, click below.Updates (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Aspergillosis infections and the lung
Wednesday, April 5, 2017 - 11:00Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 5, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Nasilele Simukulva: Chronic Pulmonary Aspergillosis
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 8, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Stephen Entwistle: Chronic Pulmonary Aspergillosis
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 8, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Jacqueline: Chronic Pulmonary Aspergillosis
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 8, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

John Guto: Chronic Pulmonary Aspergillosis
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 8, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

UK Aspergillosis as Primary Diagnosis 1998 - 2015
Post date: Mar 2017 (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 7, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

8th Advances Against Aspergillosis
Date: Monday, February 13, 2017Year: 2018Location: Lisboa Congress Centre, Lisbon, PortugalContent-type: current_conferences (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 13, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

ATS Patients Information Series: Aspergillosis
Part of the American Thoracic Society's Patient Information series intended for the laypersonMonday, February 13, 2017 - 15:33Updates (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 13, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Aspergillosis Hospitalisations Rise 50%
Mon, 02/06/2017 - 16:53News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 6, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

CEO Becomes an Aspergillosis Survivor
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - January 25, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation
Condition:  Invasive Aspergillosis Intervention:  Sponsor:  European Group for Blood and Marrow TransplantationRecruiting - verified January 2017Tuesday, January 17, 2017 - 13:25Updates (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - January 17, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Invasive pulmonary aspergillosis after near-drowning - Tavazzi G, Via G, Marzani FC, Mojoli F.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - December 28, 2016 Category: Global & Universal Tags: Drowning, Suffocation Source Type: news

Lupin launches voriconazole tablets
The medicines are indicated for use in patients 12 years of age and older in the treatment of fungal infections, including invasive Aspergillosis, Candidemia in non-neutropenic patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2016 Category: Pharmaceuticals Source Type: news

Marijuana use and aspergillosis
Marijuana PlantsPost date: Dec 2016 (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - December 9, 2016 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Aspergillosis in AIDS, A Complex Problem
Thu, 11/24/2016 - 16:40News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 24, 2016 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Invasive Mycoses: Emerging Paradigms and Practical Applications
Invasive Mycoses: Emerging Paradigms& Practical Applicationsis an enduring activity based on content presented at the 2016 MSGERC symposium at ASM Microbe. With content spanning from updates on diagnostics and pharmacologic considerations for therapies to challenges in the management of invasive aspergillosis, invasive mucormycosis, and breakthrough infections, this activity addresses key clinical issues for optimal invasive fungal disease (IFD) management.Courses& Workshops (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 22, 2016 Category: Respiratory Medicine Authors: GAtherton Source Type: news